Design-Elememt

Biotech partnering

 
On these webpages, start-up companies can locate contacts within the vfa member companies for potential collaboration as well as informative guidelines regarding the information an interested start-up company should prepare for its initial contact with a research-based pharmaceutical company. Through collaborations and strategic alliances, both partners can contribute their individual strong points.

AbbVie Deutschland GmbH & Co. KG

Contact

Dr. Frank-Christophe Lintz
Associate Director Crossfunctional Projects

Telephone: +49 621 589-3244
Telefax: +49 621 589-63244

Scope of collaboration
  • Research & Development
  • Project
  • Technology
  • Product
  • Licence
  • Strategic alliances
  • Shareholding
Offer
  • Product development
  • Formulation development
  • Clinical Development
  • Authorisation
  • Marketing & Distribution
Request
  • Projects
    • Therapeutics from pre-clinical

  • Drug Discovery
    • New Targets
    • New Technologies
    • Pre-clinical programmes (small molecules, biologics)
    • Formulation development
Indications
  • Immunology/Inflammation (Joints, Gastroenterology, Dermatology u. a.
  • CNS Diseases/Neurodegenerative Diseases
  • Onkology
  • Virology

Actelion Pharmaceuticals Deutschland GmbH

Contact

Michael Danzl
General Manager

Telephone: +49 761 4564-11
Telefax: +49 761 4564-45

Scope of collaboration
  • Product
  • Licence
  • Distribution
Offer
  • Marketing & Distribution
Request
  • Products of phase II - III
  • HT-Screening
  • Chemical Libraries
  • Formulation development
  • Small Molecules
  • Target Search
Indications
  • Pulmonary diseases
  • Cardiovascular diseases
  • Oncology
  • Gastroenterology/metabolism

AMGEN GmbH

Contact

Dr. Karl-Heinz Grajer
Executive Managing Director

Telephone: +49 89 149096-1600
Telefax: +49 89 149096-2600

Scope of collaboration
  • Product
  • Technology
  • License
  • Distribution
  • Shareholding
Request
  • Gene Therapy
  • Functional genomics
  • Neurology
  • Neurotrophe factors
  • Small molecules
Indications
  • Nephrology
  • Oncology
  • Orphan diseases
  • Osteology
  • Cardiology


apceth GmbH & Co. KG

Contact

Dr. Christine Günther
CEO

Telephone: +49 89 7009-608-0
Telefax: +49 89 7009-608-130

Astellas Pharma GmbH

Contact

Norbert Fischer
Marketing Director

Telephone: +49 89 4544-1336
Telefax: +49 89 4544-5336

Scope of collaboration
  • Co-development
  • Licence
  • Product purchase
Indications
  • Immunology/allergology
  • Anti-infection agents
  • pulmonary diseases
  • Cardiovascular diseases
  • Oncologics
  • Pain
  • Dermatology
  • Urology


AstraZeneca GmbH

Contact

Dr. Stefan Busch
VP Strategic Planning Portfoliomanagement

Telephone: +49 4103 708-3739
Scope of collaboration
  • Development
  • Technology
  • Product
  • Licence
  • Distribution
  • Strategic alliances
Offer
  • Product development
  • Formulation development
  • Production
  • Clinical development
  • Product sales
  • Licensing
  • Marketing & distribution
Request
  • Therapeutics/diagnostics from phase II and III
  • Drug discovery
    • Angiogenesis
    • Cell cycling
    • Cytokines
    • Formulation development
    • Functional genomics
    • Small molecules
    • Target search
    • Pharmacogenetic

Indications
  • AIDS/HIV-infections
  • Allergy
  • Alzheimer´s disease
  • Anti-infective
  • Pulmonary diseases
  • Gynaecology
  • Cardiovascular diseases
  • Vaccines
  • Oncology
  • Paediatry
  • Pain
  • Urology
  • CNS


BAYER AG

Contact

Dr. Mark Wolters
Bayer Life Science Center, Early Licensing

Telephone: +49 30 468-12559
Scope of collaboration
  • Project
  • Technology
  • Licence
  • Strategic alliances
  • Shareholding
Offer
  • Marketing & Distribution
  • Product development
    • Medical Chemistry
    • PK/PD
    • Toxicology

  • Formulation development
  • Production
  • Production of recombinant proteins
Request
  • Therapeutics in all phase of development
  • Chemical libraries
  • Small molecules
  • Biologics
Indications
  • Cardiology & Haematology
  • Gynaecological therapies
  • Oncology
  • Ophtalmology

BERLIN CHEMIE AG

Contact

Annika Eicke
Head Business Development

Telephone: +49 30 6707-3619
Telefax: +49 30 6707-2440

Scope of collaboration
  • Development
  • Product
  • License
  • Distribution
  • Strategic Alliances
Offer
  • Product Development
  • Development of Formulations
  • Clinical Development
  • Regulatory Affairs
  • Licensing
  • Marketing & Vertrieb
Request
  • Therapeutic Agents/Diagnostica from Phase II
Indications
  • Anti-Infectiva
  • Alzheimer's Disease
  • Respiratory Diseases
  • Dermatology
  • Diagnostics
  • Endocrinology
  • Cardiovascular Diseases
  • Immunology/Allergology
  • Musculoskeletal Disorders
  • Nephrology
  • Oncology
  • Ophtalmology
  • Pain
  • Orphan Diseases
  • Alimentary Tract/Metabolism
  • Central Nervous System

Be the Partner AG

Contact

Vanessa Fröse
Partner Accreditation

Telephone: +49 30 2639288 15
Telefax: +49 30 2639288 20

Scope of collaboration
  • Research project
  • Development project
  • Technology
  • Product
  • Licence
  • Strategic alliances
Offer
  • Product sale
  • Marketing & distribution
Request
  • Products
    • Therapeutics/diagnostics from pre-clinical to phase III
  • Drug discovery
    • Angiogenesis
    • Cell cycling
    • Cell therapy
    • Functional genomics
Indications
  • Cardiovasculare diseases
  • Immunology/allergology
  • Oncology

Biogen GmbH

Contact

Stefan Schneider
Director Communications

Telephone: +49 89 99617-283
Scope of collaboration
  • Licence
  • Distribution
  • Strategic alliances
Indications
  • Neurology
  • Dermatology


Bristol-Myers Squibb GmbH & Co. KGaA

Contact

Gerald Feger
Associate Director Business Development

Telephone: +49 89 12142-460
Telefax: +49 89 12142-519

Scope of collaboration
  • License
  • Distribution
Indications
  • Cardiovascular diseases
  • Oncology
  • CNS
  • Anti-infective agents/HIV
  • Metabolism

C. H. Boehringer Sohn AG & Co. KG

Contact

Prof. Dr. Uwe Bücheler
CEO

Telephone: +49 6132 77 0
Telefax: +49 6132 72 0

Scope of collaboration
  • Development
  • Project
  • Technology
  • Product
  • Strategic alliances
Offer
  • Product development
  • Formulation development
  • Production
  • Regulatory affairs
Request
  • Therapeutics/diagnostics from pre-clinical phase I - III
  • Production of recombinant proteins
  • all biopharmaceutical products on the basis of mammal cell cultures + microorganism
  • Formulierungsentwicklung
  • Functional Genomics

Daiichi Sankyo Deutschland GmbH

Contact

Dr. med. Bernhard R. Höhne
Head of Business Developm & Alliance Mgt.

Telephone: +49 89 7808-285
Telefax: +49 89 7808-99285

Scope of collaboration
  • License
  • Distribution
  • Strategic alliances
Offer
  • Clinical development
  • Regulatory affairs
  • Licensing
  • Marketing & Distribution
Request
  • Therapeutics/diagnostics clinical phase I
Indications
  • Anti-infection agents/HIV
  • Pulmonary diseases
  • Cardiovascular diseases
  • Immunology/Allergology
  • Musculoskeletal disorders
  • Oncology
  • Gastroenterology/Aetabolism
  • Diabetes

EISAI GmbH

Contact

Astrid Richter
Legal Director

Telephone: +49 69 66585-0
Telefax: +49 69 66585-25

Scope of collaboration
  • Co-marketing
  • Co-promotion
  • Co-selling
Offer
  • Co-marketing
  • Co-selling
Request
  • Oncology
  • CNS

Genzyme GmbH (ein Unternehmen der Sanofi-Gruppe)

Contact

Dr. Olaf Ritzeler
R&D S&I - Strategy, Science Policy & External Innovation

Telephone: +49 69 305 83046
Telefax: +49 69 305 27454

GlaxoSmithKline GmbH & Co. KG

Contact

Prof. Dr. Torsten Strohmeyer
Director Research & Development

Telephone: +49 89 36044-8600
Telefax: +49 89 36044-98600

Scope of collaboration
  • Product
  • License
  • Venture Capital
Request
  • Anti-infective agents
  • Pulmonary diseases
  • Oncology
  • Cardiovascular diseases
  • Metabolism
  • CNS

Grünenthal GmbH

Contact

Dr. Ulrich Jahnel
Head External Innovation Pain

Telephone: +49 241 569-2425
Telefax: +49 241 569-1511

Scope of collaboration
  • Project
  • Product
  • Technology
  • License
  • Distribution
  • Venture Capital
  • Shareholding
Request
  • Pain
  • Inflammatory diseases
  • Acquisitions (Products, Enterprises) in Latinamerica

Janssen-Cilag GmbH

Contact

Dr. Isabel von Korff
J&J Innovation Liaison Manager; Manager Medical & Scientific Innovations

Telephone: +49 2137 955-4766


Dr. Klaus Suwelack
J&J Innovation Liaison Manager; Senior Manager New Business Development & Innovation Management

Telephone: +49 2137 955-330
Scope of collaboration
  • Product
  • License
  • Distribution
  • Strategic Alliances
Offer
  • Clinical Development
  • Licensing
  • Marketing & Distribution
Request
  • Therapeutics/diagnostics phase II and III
Indications
  • Anti- infective
  • Pulmonary diseases
  • Dermatology
  • Diabetes
  • Cardiovascular diseases
  • Nephrology
  • Oncology
  • Pain
  • Virology
  • CNS


Lilly Holding GmbH

Contact

Horst Meurers
Manager B2B & Contracting

Telephone: +49 6172 273-2424
Scope of collaboration
  • License
  • Distribution
  • Stategic Alliances
Offer
  • Distribution + licensing of marketed products
  • Field service cooperation
Request
  • Therapeutics/diagnostics of clinical phase I - III
Indications
  • Oncology
  • Endocrinology, esp. diabetes
  • Neurology
  • Autoimmune diseases, esp. rheumatology, dermatology

Lundbeck GmbH

Contact

Dr. Eberhard Lüdtke
Marketing Director

Telephone: +49 40 23649-237
Telefax: +49 40 23649-255

Scope of collaboration
  • on request

Medigene AG

Contact

Dr. Kerstin Pino Tossi
Business Development

Telephone: +49 89 200033-3306
Telefax: +49 89 200033-3330

Scope of collaboration
  • Development
  • Technology
  • Product
  • Licence
  • Distribution
Offer
  • Licensing
Indications
  • Oncology
  • Immunology


MERCK KGaA

Contact

Dr. Sandra von Meier
Global Business Development and Alliance Management

Telephone: +49 6151 72-34229
Scope of collaboration
  • Research
  • Development
  • Technology
  • Product
  • License
  • Strategic Alliances
  • Shareholding
  • Financing projects
Offer
  • Product development
  • Further (Merck Millipore): Technologies, Solutions and Working instruments for Life-Science Research and pharmaceutical Production
Request
  • Therapeutics/diagnostics from pre-clinical phase to phase III
  • Medicinal products
  • Medicinal technologies
  • Technological Platforms
Indications
  • Oncology
  • Immuno-Oncology
  • Immunology
  • Mutiple Sclerosis
  • Fertility treatment


MOLOGEN AG

Contact

Dr. Moritz Beissenhirtz
Director of Business Development and IP

Telephone: +49 30 841788-0
Telefax: +49 30 841788-50

Scope of collaboration
  • Licence/Partnering
  • Clinical Development
  • Technologies
  • Strategic alliances
Offer
  • Onkology
  • Immunotherapeutical agents
  • Severe infectious diseases
  • Integrated therapies
  • TLR-9 Agonists
Indications
  • Cancer
    • Bowel cancer
    • Lung cancer
    • Solid tumors

  • Infektious diseases
    • HIV

MSD SHARP & DOHME GmbH

Contact

Dr. Renate Bertling
Head of Business Development

Telephone: +49 89 4561-1145
Telefax: +49 89 4561-1295

Scope of collaboration
  • Product
  • License
  • Distribution
  • Strategic alliances
Offer
  • Product sales
  • Licensing
  • Marketing & Distribution

Mundipharma GmbH

Contact

Dr. Ingrid Spohr
Head of Medicine

Telephone: +49 6431 701-411
Telefax: +49 6431 701-433

Scope of collaboration
  • License
  • Distribution
  • Strategic alliances
Offer
  • Clinical Development
  • Regulatory affairs
  • Licensing
  • Marketing & Distribution
Request
  • Therapeutics/diagnostics of clinical phase III
Indications
  • Oncology
  • Pain
  • Urology

NOVARTIS PHARMA GmbH

Contact

Bernhard Georg Achleitner
Head of Business Development & Licensing

Telephone: +49 911 27313-521
Telefax: +49 911 27315-521

Scope of collaboration
  • Development
  • Product
  • License
  • Distribution
  • Shareholding

PAION AG

Contact

Dr. Wolfgang Söhngen
CEO

Telephone: +49 241 4453-0
Telefax: +49 241 4453-100

Scope of collaboration
  • Development project
  • Research project
  • Product
  • Licence
  • Strategic alliances
Offer
  • Clinical development
  • Licensing
Request
  • Products
    • Therapeutics/diagnostics from pre-clinic, phase I, phase II,
  • Production
    • Production of recombinant proteins
    • Small molecules
Indications
  • Anaesthesia
  • Pain
  • CNS


Pfizer Deutschland GmbH

Contact

PD Dr. med. Peter-Andreas Löschmann
Medical Director Germany

Telephone: +49 30 550055-53185
Telefax: +49 30 550054-52147

Scope of collaboration
  • Research & Development
  • Project
  • Technology
  • Product
  • Licence
  • Strategic alliances
  • Shareholding
  • Distribution

Offer
  • Product development
  • Formulation development
  • Clinical development
  • Drug regulatory affairs
  • Productsales
  • Licensing
  • Marketing & Distribution

Request
  • Products
    • Therapeutics/Diagnostics from preclinical stage
    • In-vitro-diagnostics
    • Biomarker R & D

  • Drug Discovery
    • Small molecules
    • Targeted NCEs
    • Antibody Drug Conjugates (ADCs)
    • Therapeutic proteins
    • Vaccines
    • Antibodies
    • Epigenetics
    • Pharmacokinetics, Dynamics &
      Metabolism
    • Formulation development

  • New Technologies
    • Nanoparticles/Probodies
    • Tissue-specific NCEs
    • Precision Brain Delivery
    • Cell & Gene Therapy

Indications
  • Immunology/Inflammation (Rheumatoide Arthritis, Psoriasis, ...
  • Cardiovascular diseases & Hematology
  • Rare diseases (Growth hormone deficiency, TTTR-FAP,...)
  • Neurology/Pain
  • Onkology
  • Anti-infectives


Roche Deutschland Holding GmbH

Contact

Medical Information

Telephone: +49 7624 14-2015
Telefax: +49 7624 8479

Scope of collaboration
  • Contract research
  • Joint research projects
  • Strategic alliances
Offer
  • Product development
  • Clinical development
  • Product sales
  • Licensing
Request

Sanofi-Aventis Deutschland GmbH

Contact

Dr. Olaf Ritzeler
Director Strategy, Science Policy & External Innovation

Telephone: +49 69 305 83046
Telefax: +49 69 305 27454

Scope of collaboration
  • Development
  • Project
  • Technology
  • Product
  • Licence
  • Strategic Alliances

Offer
  • Product development
  • Formulation development
  • Clinical development
  • Drug Regulatory Affairs
  • Licensing

Request
  • Products
    • Therapeutics/diagnostics from pre clinical, clinical phase I - III
    • In-vitro-diagnostics
  • Technology
    • HT-Screening
    • Protein resp. RNAi based development candidates & technology
  • Drug discovery
    • Angiogenesis
    • Cell therapy
    • ADCs
    • Cancer immunotherapy
    • Cytokines
    • Chemical libraries
    • Gene therapy
    • Formulation development
    • Functional genomics
    • Small molecules
    • Target search
    • Pharmacogenetics

Indications
  • Anti-Infective
  • Respiratory desease
  • Cardiovascular disease
  • Immunology/allergology
  • Disease of muscle/skeleton
  • Nephrology
  • Oncology
  • Ophtalmology
  • Pain
  • Gastro-intestinal diseases/metabolism
  • CNS


Takeda GmbH

Contact

Michael Bender
Market Access Analyst & New Product Planning

Telephone: +49 30 2062 77271
Scope of collaboration
  • License
  • Product
  • Distribution
  • Strategic alliances
Offer
  • Licensing
  • Marketing & distribution
Request
  • Therapeutics/diagnostics from phase III
Indications
  • Pulmonary diseases
  • Gynaecology
  • Cardiovascular diseases
  • Musculoskeletal disorders
  • Nephrology
  • Oncology
  • Pain
  • Urology
  • Gastroenterology/metabolism
  • CNS


UCB GmbH

Contact

Peter Mitterhofer
Managing Director

Telephone: +49 2173 482333
Telefax: +49 2173 481032

Scope of collaboration
  • Research project
  • Development project
  • Technology
  • Product
  • Licence
  • Distribution
  • Strategic alliances
  • Shareholding
Offer
  • Licensing
  • Marketing & distribution
Request
  • Products
    • Therapeutics/diagnostics from pre-clinical to phase III
    • In-vitro-diagnostics
  • Drug Discovery
    • Angiogenesis
    • Cell cycling
    • Cell therapy
    • Cytotoxic agents
    • Cytokines
    • Chemical libraries
    • Gene therapy
    • Formulation development
    • Functional genomics
    • Small molecules
    • Target search
    • Pharmacogenetics
    • Further: biopharmaceuticals

Indications
  • Allergology
  • Alzheimer's
  • Pulmonary diseases
  • Diagnostics
  • Dermatology
  • Endocrinology
  • Gynaecology
  • Cardiovasculare diseases
  • Immunology/allergology
  • Musculoskeletal disorders
  • Nephrology
  • Oncology
  • Paediatrics
  • Pain
  • CNS
  • Further: internal medicine

Vifor Deutschland GmbH

Contact

Dr. Stefanie Wesche
Senior Manager Strategic Marketing + Alliances

Telephone: +49 89 324918-615
Telefax: +49 89 324918-601

The Pharmaceutical Industry in Germany

Germany: The Perfect Location for Research, Production and Sales - a publication by GERMANY TRADE & INVEST and vfa
Brochure Download